Dear Friends and Colleagues,
The goal of securing the future of the field of allergy and clinical immunology permeates everything that the World Allergy Organization (WAO) does and strives to accomplish. It is with that in mind that WAO funds educational programs like the World Allergy Training Schools (WATS) of the Emerging Societies Program (ESP) and why we foster initiatives that promote the development of societies and support of physicians in the developing world. That is also why it is so important to WAO that we host our congresses, conferences and symposia annually. The specialty as a whole is only as strong as the ties that bind us together. >>Read More...
Inside the Issue
- Meet Your WAO Leaders: Dr. Stanley Fineman
- Upcoming COSA Symposium at WISC 2016 – Save the Date!
- New! Bronchial Thermoplasty Online Learning
- Severe Asthma: Advancing the Art of Control – Dinner Symposium
- World Allergy Training School (WATS), Puebla, Mexico
- New Summary! Allergic Diseases Resource Center
- New Question! Ask the World’s Experts
- WAO Website and WAO News & Notes Win Awards
- Thank You, Website Translators!
- Call for Allergy Quizzes
- WAO Social Media Update
- New! WAO Journal Articles
Upcoming WAO Meetings
WAO International Scientific Conference 2016
Register today to attend cutting-edge sessions at WISC 2016!
View the Online Scientific Program.
Advance registration closes Monday, 28 November at midnight CDT. Onsite registration will be available.
WAO Symposium on Hot Topics
in Pediatric Allergy and Regulatory Affairs
Save the Date!
27-29 April 2017
Rome, Italy/Vatican City
Visit www.worldallergy.org/rome2017 for more information.
Stanley Fineman, MD, MBA
Atlanta Allergy and Asthma Clinic
Atlanta, Georgia, USA
Member Society: American College of Allergy, Asthma and Immunology
Member-at-Large, WAO Board of Directors
What inspired you to become more involved in WAO?
As an officer in the American College of Allergy, Asthma & Immunology (ACAAI) I had the opportunity to see firsthand the beneficial programs and impact that the WAO has on its member societies and ultimately on improvement in care for allergy patients all around the globe.
What would you like to share about the work of your national member society?
I have previously been involved in the Practice Parameters committee, but recently I’ve been active in our anaphylaxis and practice management committees. I’m on the editorial board of our journal, Annals of Allergy and the quarterly publication, Allergy Watch. The ACAAI helps support the community-based allergist. Our focus has been to direct programs that will help our members keep up with the many scientific advances in our field but also to help them improve the efficiency of their practices.
What is one of your current special interests in the field of allergy/immunology?
My basic focus has been to help improve the care for allergic patients, not just in my own practice but others as well. For that reason besides my work at ACAAI, I have been working with the Allergy Asthma Network, a patient advocacy organization whose goal is also to improve the care for allergy patients. I am a faculty member at Emory University School of Medicine and have the opportunity to teach and work with the training fellows. My current research projects include studies for new therapies for food allergy and immune deficiency.
References to most recent publications
- Allergists' self-reported adherence to anaphylaxis practice parameters and perceived barriers to care: an American College of Allergy, Asthma, and Immunology member survey
- Addressing barriers to emergency anaphylaxis care: from emergency medical services to emergency department to outpatient follow-up
- High Chinese elm pollen counts in the fall in Atlanta, Georgia, 2009–2015
COSA Symposium: Severe Asthma
Thursday, 8 December 2016
11:00 AM to 12:05 PM
Peter Howarth, University of Southampton (United Kingdom)
Neville Berkman, Hadassah Hebrew University Medical Center (Israel)
Severe Asthma Phenotypes and Fungal Allergic Respiratory Disease
Paul Greenberger, Northwestern University (United States)
Aspirin Exacerbated Respiratory Disease
Shmuel Kivity, Tel-Aviv Sourasky Medical Center (Israel)
Novel Therapies for Severe-Unresponsive Asthma
Elliot Israel, Brigham and Women’s Hospital (United States)
A COSA initiative, supported through an independent education grant from Teva Pharmaceuticals.
Learn more about the work of the Collaboration on Severe Asthma (COSA), including educational programs, scientific articles, and other online resources on severe asthma at: www.worldallergy.org/severe-asthma.
Bronchial Thermoplasty, An Option for Difficult-to-Treat Severe Asthma
This online learning module offers participants the ability to identify patients who might respond to bronchial thermoplasty, understand long-term outlook, and be aware of complications. The module is built around a case history that is based on a real-life scenario. Participants are quizzed along the way and receive explanations supported by references to relevant publications as well as other resources available online for further exploration. Access the Module
Author: Reynold Panettieri, Jr., MD
Vice Chancellor for Translational Medicine and Science, Rutgers University
Reviewer: F. Myron Zitt, MD
Associate Professor, Department of Medicine, State University of New York – Stony Brook
Course Director: Lanny J. Rosenwasser, MD
Professor, University of Missouri – Kansas City, School of Medicine
Acknowledgement: WAO thanks Boston Scientific for support through an independent education grant.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the World Allergy Organization. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this internet enduring material for a maximum number of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration is now open for this free educational event. Register Today!
Maximum of 1.5 AMA PRA CATEGORY 1 CREDIT(S)TM
Michael E. Wechsler, MD, MMSc
National Jewish Health
Parameswaran Nair, MD, PhD, FRCP, FRCPC
Mario Castro, MD, MPH
Washington University School of Medicine in St. Louis
This 90-minute symposium certified for continuing medical education will focus on the assessment and management of severe asthma, with an emphasis on eosinophilic presentations including the role of biologics, and global best practices to improve patient outcomes.
Key opinion leaders will discuss the management of severe asthma before a live audience of invited physicians and healthcare professionals who will engage with the panel via polling, case dialogue and Question/Answer opportunities.
This program is a partnership of Medscape and the World Allergy Organization. The Program Director is Lanny J. Rosenwasser, MD, University of Missouri at Kansas City, United States.
Registration on site begins at 6:00 PM.
Supported by an independent educational grant from Teva.
On 13-14 October 2016, the Emerging Societies Program (ESP), a joint initiative of the World Allergy Organization (WAO) and the American College of Allergy, Asthma & Immunology (ACAAI), along with the Puebla College of Allergy and Immunology, held a World Allergy Training School (WATS) in Puebla, Mexico. Dr. Dana Wallace, Dr. Richard Weber and Dr. David Khan represented WAO and led the Training School. A great thank you to Dr. Maria del Rocío and Dr. Désirée Larenas Linnemann for their hard work in putting together this great conference!
To view more information, visit our ESP/WATS- Puebla, Mexico page online!
Newly Updated Disease Summary!
"Allergen immunotherapy for allergic rhinitis and asthma”, By Giorgio Walter Canonica, MD, and Stephen R. Durham, MA, MD, FRCP Access
The ADRC helps you find concise overviews about allergic diseases and up-to-the-minute news of developments in allergy and asthma management and treatment which are written by the world's leading allergy experts. Visit the ARDC to view all topics in the library at: www.worldallergy.org/adrc.
Probiotics in the Treatment of Atopic Dermatitis: Are probiotics helpful in the treatment and the prevention of atopic dermatitis?
Are you curious to read what the experts have to say on this question? Click here to read their answers.
If you are a physician that would like to pose educational, scientific or medical questions about allergy, asthma and clinical immunology to WAO international experts, click here. Find a growing list of answered questions here.
WAO has been recognized in the 2016 MarCom Awards, judged and administered by the International Association of Marketing and Communications Professionals. The WAO website (www.worldallergy.org/) and WAO News & Notes both received the 2016 Gold Award, which is presented to those entries judged to exceed the high standards of the industry norm. There were over 6,000 entries worldwide.
Congratulations to Prof. Juan Carlos Ivancevich, Dr. Dana Wallace, the WAO Web Editorial Board, and all content contributors, reviewers, and translators involved in the WAO website.
Every month volunteers translate the President’s Message, Journal Article Reviews, and Book Reviews into several different languages.
WAO would like to welcome Mónica González Medina, MD, and Paula Galván Blasco, MD, as WAO translators for Spanish.
WAO would like to thank Anna Sala Cunill, MD, PhD, and Lorena Soto Retes, MD, for their many years serving as translators.
WAO also extends appreciation to these translators for their ongoing contributions:
Arabic: Yehia El-Gamal, MD, PhD, and Elham Hossny, MD, PhD
French: Liliane Gendreau-Reid, MD, FRCPC
Italian: Maria Bova, MD, PhD
Polish: Krzystof Kowal, MD, PhD
Portuguese: Herberto Jose Chong Neto, MD, PhD, FAAAAI
Get to know Mónica González Medina, MD, and Paula Galván Blasco, MD, and the other contributors, here.
If you are interested in becoming a translator and for more information contact Samantha Machart email@example.com.
Showcase your creativity and add to your CV!
Submit a quiz question with answers and explanations for the Allergy Quiz Section of the WAO website, which is edited by Glenis Scadding, MD.
Each quiz will be featured on the homepage of the WAO website and announced in the monthly newsletter, WAO News & Notes. Join Dr. Scadding in developing an enjoyable learning experience for allergists/immunologists and trainees around the world.
For more information, contact firstname.lastname@example.org
WAO’s social media pages bring you up-to-date information about current news and events of interest to allergists/ immunologists. You also get updates on future meetings, scientific content, and what is new at www.worldallergy.org.
WAO would like to thank its followers: Now over 4,350 followers on Twitter and 3,875 likes on Facebook!
Visit both pages for the latest WAO news!
Make sure to visit both our company and group page on LinkedIn for the latest WAO news! And don’t forget about our other social media sites.
Editors' Choice Literature Review
A switch in regulatory T cells through farm-exposure during immune maturation in childhood
Atopic Dermatitis: Eczema
What's New in Small Airways Research
Aging is associated with small airway abnormality regardless of respiratory symptoms
What's New in Severe Asthma Research
Asthma phenotypes in inner-city children
Cow’s milk allergy: towards an update of DRACMA guidelines View Article
Manifesto on small airways involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association – GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) View Article
Effects of poor hygiene on cytokine phenotypes in children in the tropics View Article
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement View Article